`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner
`
`v.
`
`HORIZON THERAPEUTICS, LLC,
`Patent Owner
`
`__________
`
`
`Case IPR2017-01767
`Patent 9,254,278
`
`__________
`
`
`NOTICE OF DEPOSITION OF DR. NEAL SONDHEIMER
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.53(d)(4), the Patent Owner hereby provides
`
`notice to the Petitioner that the deposition of Dr. Neal Sondheimer in this inter
`
`partes review will commence Thursday, April 19, 2018, 9:00 am Eastern Time,
`
`and will continue day-to-day until completed at the offices Victory Verbatim, 222
`
`Bay Street, Suite 900 and Suite 1710, Toronto, Ontario, Canada M5K1H6. The
`
`deposition will be conducted before an officer authorized to administer oaths and
`
`will be recorded by a stenographer.
`
`Pursuant to 37 C.F.R. § 42.53(d)(1), the parties have conferred and have
`
`agreed on this date and location for Dr. Sondheimer’s deposition.
`
`
`
`Date: April 5, 2018
`
`
`
`Respectfully submitted,
`
`By: / M.C. Phillips /
`Matthew C. Phillips
`Reg. No. 43,403
`Counsel for Patent Owner
`
`
`IPR2017-01767
`
`Notice of Deposition of Dr. Neal Sondheimer
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on April 5, 2018, copies of the foregoing NOTICE OF
`
`DEPOSITION OF DR. NEAL SONDHEIMER and all documents filed with it
`
`were served via electronic mail, as agreed to by counsel, upon the following
`
`counsel for the Petitioner:
`
`David G. Silverstein: dsilverstein@axinn.com
`
`Dan Feng Mei: dmei@axinn.com; Ravicti@axinn.com
`
`
`
`
`
`
`
`
`By: / M.C. Phillips /
`Matthew C. Phillips
`Reg. No. 43,403
`Counsel for Patent Owner
`
`IPR2017-01767
`
`Notice of Deposition of Dr. Neal Sondheimer
`
`
`
`